2020
DOI: 10.1016/j.scitotenv.2020.136710
|View full text |Cite
|
Sign up to set email alerts
|

Bayesian inference of nonylphenol exposure for assessing human dietary risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 52 publications
0
6
0
Order By: Relevance
“…Assuming an ingestion rate of 950 particles per day and the microplastics-associated concentrations of 400 mg/kg for pyrene and 4000 mg/kg for 4-nonylphenol (both are within the concentration levels involved in the bioaccessibility tests), and using the bioaccessibility observed in this study, the calculated daily intake values are 3.28 × 10 –4 to 1.58 × 10 –3 mg/kg/day for pyrene and 1.51× 10 –2 to 4.78 × 10 –2 mg/kg/day for 4-nonylphenol. These values correlate to a carcinogenic risk of 2.40 × 10 –6 to 1.15 × 10 –5 for pyrene, and a hazard quotient of 3.01–9.56 for 4-nonylphenol (a hazard quotient value equal to or above 1 indicates noncarcinogenic risk) . As a caveat, the concentrations of xenobiotics used in this study are relatively high, and the actual bioaccessibility may be lower when gastrointestinal fluids contain xenobiotics from other sources (e.g., contaminated foods).…”
Section: Resultsmentioning
confidence: 84%
See 1 more Smart Citation
“…Assuming an ingestion rate of 950 particles per day and the microplastics-associated concentrations of 400 mg/kg for pyrene and 4000 mg/kg for 4-nonylphenol (both are within the concentration levels involved in the bioaccessibility tests), and using the bioaccessibility observed in this study, the calculated daily intake values are 3.28 × 10 –4 to 1.58 × 10 –3 mg/kg/day for pyrene and 1.51× 10 –2 to 4.78 × 10 –2 mg/kg/day for 4-nonylphenol. These values correlate to a carcinogenic risk of 2.40 × 10 –6 to 1.15 × 10 –5 for pyrene, and a hazard quotient of 3.01–9.56 for 4-nonylphenol (a hazard quotient value equal to or above 1 indicates noncarcinogenic risk) . As a caveat, the concentrations of xenobiotics used in this study are relatively high, and the actual bioaccessibility may be lower when gastrointestinal fluids contain xenobiotics from other sources (e.g., contaminated foods).…”
Section: Resultsmentioning
confidence: 84%
“…These values correlate to a carcinogenic risk of 2.40 × 10 −6 to 1.15 × 10 −5 for pyrene, and a hazard quotient of 3.01−9.56 for 4-nonylphenol (a hazard quotient value equal to or above 1 indicates noncarcinogenic risk). 65 As a caveat, the concentrations of xenobiotics used in this study are relatively high, and the actual bioaccessibility may be lower when gastrointestinal fluids contain xenobiotics from other sources (e.g., contaminated foods 13 ). Thus, under normal conditions the risks of microplastics as a vector for enhancing human uptake of toxic organic xenobiotics are likely low.…”
Section: ■ Results and Discussionmentioning
confidence: 97%
“…The former handles uncertainty in data and the later handles it in the model. (Lim, 2020) 2020 COVID-19 Fallacies, facts and uncertainties about COVID-19 using Bayesian inference (Ghoshal et al, 2019) 2020 COVID-19 Uncertainty estimation in deep learning models for diagnosis of COVID-19 (Lin et al 2020) 2020 Human dietary risk Human dietary risk assessment using Bayesian inference (Zhou et al 2020) 2020 Medical image reconstruction Uncertainty quantification and Bayesian inference for the reconstruction of the medical image using Poisson data (Akkoyun et al 2020) 2020 Abdominal aortic aneurysm Abdominal aortic aneurysm prediction using two-step Bayesian inference (Magnusson et al 2019) 2019 Medical data analysis Principal stratum estimand to examine the effect of treatment in a subgroup using Bayesian Inference (Lipková, 2019) (Johnston et al 2015) 2015 Bioinformatics MtDNA bottleneck mechanism using Bayesian inference and Stochastic modeling (Huang et al 2011) 2011 HIV HIV dynamics with longitudinal data (Huang et al 2010) 2010 HIV HIV dynamic differential equation models using hierarchical Bayesian inference (Robertson & DeHart, 2010) 2010 Medical decision making An accessible and agile adaptation of Bayesian inference to medical diagnostics for interior health workers (Galesic et al 2009) 2009 Medical decision making Medical screening tests' evaluation with natural frequencies of older people with low numeracy (Suchard & Redelings, 2006) 2006 Bioinformatics BAli-Phy: simultaneous Bayesian inference of alignment and phylogeny (Mendoza-Blanco et al 1996) 1996 HIV A missing-data approach with simulation-based techniques on Bayesian inference prevalence related to HIV screening (Johnson & Gastwirth, 1991) 1991 Medical decision making Bayesian inference for medical screening tests Kendall et al (2017...…”
Section: Related Work Based On Bayesian Deep Learningmentioning
confidence: 99%
“…This could be ascribed to the strong bioaccumulation ability of iAs in MV species and high iAs content in the clam food chain of this culture area. Using the tAs and iAs values we observed earlier in clam samples as prior knowledge, we adopted Markov Chain Monte Carlo (MCMC) simulation to generate the posterior distributions of tAs and iAs to further estimate their concentrations in the different clam species (Lin et al, 2020). After conducting MCMC computation for the two tAs/iAs datasets, respectively, Figure 6A shows the predicted posterior distributions of the amounts of tAs(blue)/iAs(red) in five clam species cultivated along the Jiangsu coastline.…”
Section: Inorganic Asmentioning
confidence: 99%